OAC
CDTX

OMERS Administration Corp’s Cidara Therapeutics CDTX Stock Holding History

OMERS Administration Corp’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,700
Closed -$642K – 1098
2025
Q3 		$642K Buy
+6,700
New +$428K ﹤0.01% 668
2025
Q2 		– Sell
-19,300
Closed -$416K – 897
2025
Q1 		$416K Buy
19,300
+6,700
+53% +$149K ﹤0.01% 790
2024
Q4 		$339K Buy
+12,600
New +$205K ﹤0.01% 796

Other funds holding CDTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

OMERS Administration Corp's CDTX Position: Q4 2025 in Review

OMERS Administration Corp sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 6,700 shares — an estimated $642K sold.

OMERS Administration Corp first reported a position in CDTX in Q4 2024 and held it in 3 quarters. The position peaked at $642K in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

  • OMERS Administration Corp reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 6,700 Cidara Therapeutics shares in Q4 2025, an estimated $642K.
  • OMERS Administration Corp first reported a position in Cidara Therapeutics in Q4 2024 and held it in 3 quarters.
  • OMERS Administration Corp's Cidara Therapeutics position peaked at $642K in Q3 2025.
  • 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.